An artificial intelligence algorithm that evaluates clinical data to predict brain aneurysm risk levels in patients. The system provides quantitative risk stratification to support clinical decision-making for preventive interventions. Applicable to screening programs across healthcare organizations...
Manufactured by
South Korea
TALOS Corp. is a medical AI company dedicated to predicting and preventing severe diseases before they occur. Founded by neurosurgeons with extensive clinical experience, TALOS aims to shift healthcare from a treatment-centered model to a prevention-centered paradigm through data-driven medical intelligence. Its flagship solution, ANRISK®, is an AI-based risk assessment service that predicts the likelihood of brain aneurysm development using only routine health check-up data. Developed using approximately 8.8 million person-years of national healthcare data, ANRISK® has received regulatory approvals in South Korea, Japan, Vietnam, and Taiwan. The solution is currently adopted by hospitals, public healthcare institutions, health screening centers, and corporate health programs across multiple countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Netown Corporation
Taiwan · 1 relevant product
Wuhan Jiule Technology Co., Ltd
China · 2 relevant products
Mediwhale Inc.
South Korea · 1 relevant product
3 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 7 closest product alternatives
Netown Corporation · Taiwan
Specialized screening platform utilizing artificial intelligence for health assessment in high-risk and vulnerable populations. Enables early identification of health conditions requiring intervention.
Wuhan Jiule Technology Co., Ltd · China
Risk stratification system for chronic disease identification through continuous health parameter monitoring. Leverages AI algorithms and wearable sensor data for predictive health risk evaluation.
Mediwhale Inc. · South Korea
AI system that analyzes retinal images to predict kidney disease risk. Leverages retinal biomarkers to identify patients at elevated risk for progressive kidney disease.
4 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products